Skip to main content
Aligned Genetics, Inc. logo

Aligned Genetics, Inc. — Investor Relations & Filings

Ticker · 238120 ISIN · KR7238120000 KO Manufacturing
Open in API
Filings indexed 140 across all filing types
Latest filing 2020-07-08 Regulatory Filings
Country KR South Korea
Listing KO 238120

About Aligned Genetics, Inc.

https://en.alignedgenetics.com

Aligned Genetics, Inc. is a company that develops, manufactures, and sells advanced solutions for cellular imaging, biomolecular analysis, and molecular diagnostics. It provides cutting-edge equipment, automated systems, imaging instruments, and reagents for laboratories in the life science and medical fields. The company focuses on developing molecular diagnostic solutions that deliver rapid and accurate results to support faster clinical care. Aligned Genetics aims to improve human health by creating technologies that offer deeper insights into cellular and molecular processes.

Recent filings

Filing Released Lang Actions
기타경영사항(특허권취득)(자율공시)(핵산증폭반응산물을 실시간으로 검출하는 장치)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent by Logos BioSystems. It details the patent name, content, and its application in the company's business. Since this is a regulatory announcement of a specific corporate event (patent acquisition) that does not fit into financial reporting, M&A, or governance categories, it falls under the general regulatory filing category.
2020-07-08 Korean
주요사항보고서(무상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean financial authorities regarding a 'Decision on Bonus Issue' (무상증자결정). This involves the issuance of new shares to existing shareholders, which falls under capital changes. According to the provided definitions, 'Share Issue/Capital Change' (SHA) is the appropriate category for announcements regarding new share issues or capital structure changes.
2020-07-06 Korean
주권매매거래정지(무상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a short regulatory notice regarding the temporary suspension of stock trading ('주권매매거래정지') for Logos BioSystems due to a bonus issue ('무상증자'). It cites KOSDAQ market regulations and specifies the duration of the suspension. Since it is a regulatory announcement regarding trading status and does not fit into specific categories like share issuance or delisting, it falls under the general regulatory filing category.
2020-07-06 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for the company Logos Biosystems. It details the date, time, location, and the agenda items (such as company name change and appointment of an auditor). This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of upcoming voting matters, which falls under the Proxy Solicitation & Information Statement category.
2020-07-06 Korean
주주명부폐쇄기간또는기준일설정
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory announcement regarding the suspension of share registration (closing of the shareholder register) for Logos Bio. It specifies a record date (2020-07-21) and the reasons for the closure, which are related to a bonus issue and an extraordinary general meeting. Since this is a standard regulatory disclosure regarding corporate actions and does not fit into specific categories like dividend announcements or share buybacks, it is classified as a general regulatory filing.
2020-07-06 Korean
기타경영사항(자율공시)(잔존혈액암세포 검사용 머신러닝 이미지 해석 기반 혈구 분석시스템 개발 협약체결 [국책과제 선정])
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure ('자율공시') by Logos Biosystems regarding the selection of a government-funded research project ('국책과제 선정') and the signing of a development agreement. It details the project scope, funding, and expected impact. Since it does not fit into specific categories like financial reports, dividends, or M&A, and is a regulatory announcement of a business development, it falls under the 'Regulatory Filings' category.
2020-05-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.